loading
Precedente Chiudi:
$0.824
Aprire:
$0.825
Volume 24 ore:
73,125
Relative Volume:
0.39
Capitalizzazione di mercato:
$27.51M
Reddito:
$4.14M
Utile/perdita netta:
$-5.58M
Rapporto P/E:
-4.08
EPS:
-0.1863
Flusso di cassa netto:
$-2.98M
1 W Prestazione:
-2.58%
1M Prestazione:
-10.52%
6M Prestazione:
-16.47%
1 anno Prestazione:
-47.58%
Intervallo 1D:
Value
$0.7601
$0.8649
Intervallo di 1 settimana:
Value
$0.7429
$0.8649
Portata 52W:
Value
$0.711
$1.55

Dyadic International Inc De Stock (DYAI) Company Profile

Name
Nome
Dyadic International Inc De
Name
Telefono
561-743-8333
Name
Indirizzo
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Name
Dipendente
6
Name
Cinguettio
@DyadicInc
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
DYAI's Discussions on Twitter

Compare DYAI vs PSNYW, SHMD, GOODO, DWLD, QQQE

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
1.69 0 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
4.50 350.59M 2.07B -1.42B -1.37B -0.6765
 icon
SHMD
Schmid Group N V
7.26 465.95M 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.18 372.90M 0 0 0 0.00
 icon
DWLD
Davis Select Worldwide ETF
45.25 0 0 0 0 0.00
 icon
QQQE
Direxion NASDAQ-100 Equal Weigh
103.33 0 0 0 0 0.00

Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-23 Ripresa H.C. Wainwright Buy
2025-09-08 Iniziato Craig Hallum Buy
2022-07-18 Downgrade Dawson James Buy → Neutral
2021-12-17 Iniziato H.C. Wainwright Buy

Dyadic International Inc De Borsa (DYAI) Ultime notizie

pulisher
Mar 02, 2026

Dyadic Applied BioSolutions and Inzymes ApS Announce - GlobeNewswire

Mar 02, 2026
pulisher
Feb 24, 2026

Dyadic's Strategic Pivot: From Platform to Product - AD HOC NEWS

Feb 24, 2026
pulisher
Feb 17, 2026

Dyadic Applied BioSolutions and Proliant Health & - GlobeNewswire

Feb 17, 2026
pulisher
Feb 16, 2026

Segmentation, Major Trends, and Competitive Overview of the Industrial Biocatalysts Market - openPR.com

Feb 16, 2026
pulisher
Feb 02, 2026

Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com

Feb 02, 2026
pulisher
Jan 24, 2026

Dyadic International (NASDAQ:DYAI) Stock Passes Below Fifty Day Moving Average – Should You Sell? - Defense World

Jan 24, 2026
pulisher
Jan 16, 2026

Dyadic International (NASDAQ:DYAI) Share Price Crosses Below 50 Day Moving Average – Should You Sell? - Defense World

Jan 16, 2026
pulisher
Jan 04, 2026

Dyadic International’s Tiny Stock, Big Volatility: Can DYAI’s Latest Rally Really Last? - AD HOC NEWS

Jan 04, 2026
pulisher
Jan 02, 2026

Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com

Jan 02, 2026
pulisher
Jan 02, 2026

Dyadic International Inc. (NASDAQ:DYAI) Short Interest Up 25.7% in December - Defense World

Jan 02, 2026
pulisher
Jan 01, 2026

iAccess Alpha’s Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Ventura County Star

Jan 01, 2026
pulisher
Dec 29, 2025

Dyadic International Amends Convertible Notes, Extends Maturity Timeline - TipRanks

Dec 29, 2025
pulisher
Dec 29, 2025

Dyadic International receives Nasdaq notice for minimum bid price deficiency - Investing.com

Dec 29, 2025
pulisher
Dec 29, 2025

Dyadic International receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com UK

Dec 29, 2025
pulisher
Dec 17, 2025

Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets - GlobeNewswire

Dec 17, 2025
pulisher
Dec 17, 2025

Analysis of Market Segmentation, Major Trends, and Competitive Dynamics in the Cellulase Market - openPR.com

Dec 17, 2025
pulisher
Dec 15, 2025

Dyadic Applied BioSolutions Establishes Commercial - GlobeNewswire

Dec 15, 2025
pulisher
Dec 15, 2025

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins - Yahoo Finance

Dec 15, 2025
pulisher
Dec 08, 2025

Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Finviz

Dec 08, 2025
pulisher
Dec 08, 2025

Earnings call transcript: Dyadic’s Q3 2025 results miss forecasts, stock dips - Investing.com

Dec 08, 2025
pulisher
Dec 08, 2025

Earnings call transcript: Dyadic's Q3 2025 results miss forecasts, stock dips - Investing.com UK

Dec 08, 2025
pulisher
Dec 06, 2025

Industrial Enzymes Market worth $12.01 billion by 2030 - MarketsandMarkets

Dec 06, 2025
pulisher
Dec 01, 2025

Dyadic International’s CRISPR Leap: Future Unveiled - timothysykes.com

Dec 01, 2025
pulisher
Dec 01, 2025

iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - News & Observer

Dec 01, 2025
pulisher
Dec 01, 2025

Dyadic (DYAI) and BRIG BIO ink alpha-lactalbumin pact for global nutrition - Stock Titan

Dec 01, 2025
pulisher
Nov 28, 2025

DYAIDyadic International Inc., DE Stock Price and Quote - Finviz

Nov 28, 2025
pulisher
Nov 28, 2025

Will Dyadic International Inc. stock beat EPS estimatesJuly 2025 Volume & Verified Stock Trade Ideas - moha.gov.vn

Nov 28, 2025
pulisher
Nov 27, 2025

Taking on analysts’ expectations and winning: Apyx Medical Corp (APYX) - Setenews

Nov 27, 2025
pulisher
Nov 27, 2025

A Look at Greenidge Generation Holdings Inc (GREE) Shares in the Recent Past Indicates Growth - Setenews

Nov 27, 2025
pulisher
Nov 25, 2025

Bandera Partners LLC Has $1.37 Million Holdings in Dyadic International Inc. $DYAI - Defense World

Nov 25, 2025
pulisher
Nov 25, 2025

AXQ Capital LP Sells 411 Shares of Acuity, Inc. $AYI - Defense World

Nov 25, 2025
pulisher
Nov 16, 2025

What momentum shifts mean for Dyadic International Inc.Trade Volume Summary & Weekly Top Gainers Alerts - newser.com

Nov 16, 2025
pulisher
Nov 13, 2025

Dyadic International’s Earnings Call: Cautious Optimism Amid Challenges - TipRanks

Nov 13, 2025
pulisher
Nov 13, 2025

Dyadic (DYAI) Q3 2025 Earnings Call Transcript - AOL.com

Nov 13, 2025
pulisher
Nov 13, 2025

Dyadic International Inc (DYAI) Q3 2025 Earnings Call Highlights: Transition to Commercial ... By GuruFocus - Investing.com Canada

Nov 13, 2025
pulisher
Nov 12, 2025

Dyadic Applied BioSolutions Reports Q3 2025 Earnings and Strategic Shift - TipRanks

Nov 12, 2025
pulisher
Nov 12, 2025

Earnings call transcript: Dyadic International Q3 2025 sees revenue miss, stock dips - Investing.com Australia

Nov 12, 2025
pulisher
Nov 12, 2025

Dyadic (NASDAQ: DYAI) rebrands, shifts to commercial focus; third‑quarter revenue $1.165M - Stock Titan

Nov 12, 2025
pulisher
Nov 11, 2025

Dyadic International Inc (DYAI) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Nov 11, 2025

Dyadic International Inc De Azioni (DYAI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Capitalizzazione:     |  Volume (24 ore):